Leica, Abbott Developing Automated FISH Test for HER2 | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Leica Microsystems and Abbott today announced a deal to develop a fully automated fluorescent in situ hybridization solution for HER2 testing.

Under the terms of the deal, Abbott will supply FISH probes targeting the HER2 gene locus, which will be used to develop the automated HER2 FISH test on Leica's BOND automated advanced staining platform.

Terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.